Frequency Therapeutics gets a $32M startup round to help fine tune its hearing loss drug R&D
A recent arrival in the new wave of regenerative medicine 2.0 biotechs taking shape has now collected a $32 million Series A for the next …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
